Follow
Kalipso Chalkidou
Kalipso Chalkidou
Global Fund to Fight AIDS TB and Malaria
Verified email at imperial.ac.uk - Homepage
Title
Cited by
Cited by
Year
A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers
KE Thorpe, M Zwarenstein, AD Oxman, S Treweek, CD Furberg, ...
Journal of clinical epidemiology 62 (5), 464-475, 2009
16052009
Evidence for overuse of medical services around the world
S Brownlee, K Chalkidou, J Doust, AG Elshaug, P Glasziou, I Heath, ...
The Lancet 390 (10090), 156-168, 2017
9082017
NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4
JE Bennett, GA Stevens, CD Mathers, R Bonita, J Rehm, ME Kruk, ...
The lancet 392 (10152), 1072-1088, 2018
8702018
Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer
K Halkidou, L Gaughan, S Cook, HY Leung, DE Neal, CN Robson
The Prostate 59 (2), 177-189, 2004
7012004
How to formulate research recommendations
P Brown, K Brunnhuber, K Chalkidou, I Chalmers, M Clarke, M Fenton, ...
Bmj 333 (7572), 804-806, 2006
3122006
Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development
K Halkidou, VJ Gnanapragasam, PB Mehta, IR Logan, ME Brady, S Cook, ...
Oncogene 22 (16), 2466-2477, 2003
2732003
NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4
JE Bennett, V Kontis, CD Mathers, M Guillot, J Rehm, K Chalkidou, ...
The Lancet 396 (10255), 918-934, 2020
2662020
Comparative effectiveness research and evidence‐based health policy: experience from four countries
K Chalkidou, S Tunis, R Lopert, L Rochaix, PT Sawicki, M Nasser, B Xerri
The Milbank Quarterly 87 (2), 339-367, 2009
1992009
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries
K Chalkidou, P Marquez, PK Dhillon, Y Teerawattananon, ...
The lancet oncology 15 (3), e119-e131, 2014
1792014
The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research
K Chalkidou, S Tunis, D Whicher, R Fowler, M Zwarenstein
Clinical trials 9 (4), 436-446, 2012
1722012
Priority-setting for achieving universal health coverage
K Chalkidou, A Glassman, R Marten, J Vega, Y Teerawattananon, ...
Bulletin of the World Health Organization 94 (6), 462, 2016
1652016
Priority-setting in health: building institutions for smarter public spending
A Glassman, K Chalkidou
Washington, DC: Center for Global Development, 2012
1372012
Searching for cost effectiveness thresholds in the NHS
J Appleby, N Devlin, D Parkin, M Buxton, K Chalkidou
Health policy 91 (3), 239-245, 2009
1372009
Protocol for the development of guidance for stakeholder engagement in health and healthcare guideline development and implementation
J Petkovic, A Riddle, EA Akl, J Khabsa, L Lytvyn, P Atwere, P Campbell, ...
Systematic reviews 9 (1), 1-11, 2020
1292020
Priority-setting institutions in health: recommendations from a center for global development working group
A Glassman, K Chalkidou, U Giedion, Y Teerawattananon, S Tunis, ...
Global heart 7 (1), 13-34, 2012
1132012
Evidence-based decision making: when should we wait for more information?
K Chalkidou, J Lord, A Fischer, P Littlejohns
Health Affairs 27 (6), 1642-1653, 2008
1022008
Recommendations from two citizens’ juries on the surgical management of obesity
PA Scuffham, R Krinks, K Chaulkidou, P Littlejohns, JA Whitty, A Wilson, ...
Obesity Surgery 28, 1745-1752, 2018
882018
NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income …
NCD Countdown
Lancet (London, England) 399 (10331), 1266, 2022
832022
Health Technology Assessment capacity development in low-and middle-income countries: Experiences from the international units of HITAP and NICE
S Tantivess, K Chalkidou, N Tritasavit, Y Teerawattananon
F1000Research 6, 2017
792017
Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate
K Halkidou, S Cook, HY Leung, DE Neal, CN Robson
European urology 45 (3), 382-389, 2004
792004
The system can't perform the operation now. Try again later.
Articles 1–20